Tower Research Capital LLC (Trc) Pds Biotechnology Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,055 shares of PDSB stock, worth $6,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,055
Previous 2,771
82.43%
Holding current value
$6,824
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding PDSB
# of Institutions
59Shares Held
4.22MCall Options Held
170KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.03 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$657,4050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$563,2420.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$333,4180.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$297,2900.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $38.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...